Relationship between chemical structure and growth-inhibitory activity of monoterpenoids against pneumonia causing bacteria in vapor phase

Read full text
Authors: Julia Werle, Anna Mascellani Bergo, Markéta Houdková, Jaroslav Havlík, Ladislav Kokoška
Cited by: 1
References: 67

Abstract

Volatile monoterpenoids represent promising candidates for inhalation-based therapies of respiratory infections due to their volatility and antimicrobial properties. Using the broth microdilution volatilization method, this study assessed the in vitro growth-inhibitory effect of 31 monoterpenoids against common pneumonia-causing pathogens, including Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes, with the aim to determine the relationship between their chemical structure and antibacterial activity in vapor phase. Among all compounds tested, β-thujaplicin, carvacrol, thymol, and thymoquinone produced the strongest antibacterial effect. A comprehensive structure-activity relationship analysis of the chemical structure indicated that monoterpenoids bearing hydroxyl or ketone functional groups on six- or seven-membered ring structures, double bonds and hydrophobic groups exhibited enhanced antibacterial potency, in vapor phase. Furthermore, statistical analysis of molecular descriptors identified critical physicochemical characteristics which are linked to their antibacterial efficacy. Those include increased polar atom content, higher electronegativity, overall hydrophobicity, and π-electron distribution. The findings of this study add valuable insights into structural and molecular determinants of antimicrobial activity and provide theoretical background for development of inhalation therapies of respiratory infections based on volatile antimicrobial terpenoids.

Fields of Study & Subjects

Natural product bioactivities and synthesis Pharmacological Effects of Natural Compounds Herbal Medicine Research Studies

Publication details

Journal / source
Bioorganic & Medicinal Chemistry Letters
Publisher
Elsevier BV
Volume
137
Pages
130663–130663
Publication date
19 April 2026
Language
EN